Search results
Penn State alumni elect three former football players to board of trustees
State College Centre Daily Times· 2 days agoNassib was a walk-on to Penn State’s football team in 2011, earning a scholarship by 2013. He led...
The Best U.S. Metros For MBA Grads To Launch Their Careers
Poets & Quants via Yahoo Finance· 6 days agoMarket analyst CoworkingCafe looked at more than 100 metros across the U.S. to determine which...
From Houston To Miami, Dean Paul Pavlou Named Herbert’s New Leader
Poets & Quants via Yahoo Finance· 1 day agoAfter serving as dean of the Bauer College of Business in Houston for five years, Paul Pavlou will...
MercadoLibre stock price surges on Wall Street after earnings
TheStreet.com· 3 hours agoHere's what could happen next to shares of MercadoLibre.
ARM Applications At Year's Highest So Far, As Rates Fail To Budge
National Mortgage Professional· 4 days agoMortgage rates won’t be on the high end forever, and more borrowers are switching to adjustable-rate...
Warning: Foundation tied to organ transplants may have taken your money
Worcester Telegram & Gazette via Yahoo News· 2 days agoNorris consulted with the Massachusetts Bar Association to explore potential legal action, and said...
InMode (INMD) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoDr. Anghel hold BA in Economics and an MBA and PhD in Finance from Columbia University. We look forward to benefiting from his financial..., assembly...
Speaker Details: Marketing Vanguard Summit 2024
AdWeek· 3 days agoPrior to joining MassMutual, Ms. Halloran held several...Head of Strategy and CMO. During her tenure, she was nominated one of the Top 20 Growth CMOs in Greater Boston... ...
Bernard Gyebi-Foster - Maryland Daily Record
The Daily Record· 6 days agoAs head of Tuerk House since 2016, the last year as the first CEO, Bernard Gyebi-Foster, MA, L.C.P.C., leads a multi-faceted...that serves nearly 300...
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of...
Lodi News-Sentinel· 2 days agoSentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases
